Reaction

Bronchitis Chronic reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,426 reports · 100 co-occurring drugs

As of the last recalculation, Bronchitis Chronic appears in 2,426 FAERS reports alongside 100 co-occurring drug terms. The strongest observed disproportionality signal is MEPERIDINE HYDROCHLORIDE (PRR 46.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Meperidine Hydrochloride	49	46.5	46.8
Moxifloxacin	44	27.3	27.4
Theophylline Anhydrous	38	26.7	26.8
Theophylline	35	26.5	26.6
Moxifloxacin Hydrochloride	53	22.9	23.0
Tocilizumab	207	16.9	17.0
Guaifenesin	50	14.3	14.4
Leflunomide	162	14.2	14.2
Budesonide And Formoterol Fumarate Dihydrate	150	14.1	14.1
Abatacept	197	13.2	13.2
Hydroxychloroquine Sulfate	130	12.9	12.9
Pitavastatin Calcium	15	12.7	12.7
Ciclesonide	17	10.8	10.8
Tiotropium Bromide Inhalation Spray	14	10.8	10.8
Meclizine Hcl 12.5Mg	17	10.8	10.8
Meclizine Hcl 25Mg	17	10.8	10.8
Meclizine Hcl 12.5 Mg	17	10.8	10.8
Meclizine Hcl 25 Mg	17	10.8	10.8
Mometasone Furoate	49	10.3	10.3
Ipratropium Bromide	41	10.0	10.0
Salmeterol Xinafoate	10	10.0	10.0
Montelukast Sodium	134	9.9	9.9
Alendronate Sodium	110	9.7	9.8
Tiotropium Bromide	147	9.7	9.7
Umeclidinium	10	9.6	9.6
Meclizine	18	9.5	9.5
Mercaptopurine	19	9.5	9.5
Fluticasone Propionate And Salmeterol	44	9.2	9.2
Budesonide, Glycopyrrolate, And Formoterol Fumarate	11	9.1	9.1
Methocarbamol Tablets	17	8.8	8.8
Fluticasone Propionate And Salmeterol Xinafoate	59	8.6	8.6
Infliximab	200	8.5	8.5
Rituximab	194	8.5	8.5
Cefuroxime	11	8.3	8.3
Erythromycin	18	8.3	8.3
Umeclidinium Bromide And Vilanterol Trifenatate	16	8.3	8.3
Acetylcysteine	9	8.2	8.2
Nicotine Polacrilex Mini	14	8.0	8.1
Nicotine Polarilex	14	8.0	8.1
Naproxen Sodium, Dextromethorphan Hydrobromide, Guaifenesin	19	8.0	8.0
Naproxen Sodium, Pseudoephedrine Hydrochloride	19	8.0	8.0
Meclizine Hydrochloride	18	7.9	7.9
Ketoprofen	12	7.9	7.9
Carisoprodol	17	7.7	7.7
Metolazone	10	7.7	7.7
Amlodipine Besylate And Benazepril Hydrochloride	8	7.5	7.5
Methocarbamol	19	7.2	7.2
Doxepin Hydrochloride	10	6.8	6.8
Levofloxacin	46	6.7	6.7
Levofloxacin In 5% Dextrose	46	6.7	6.7
Albuterol Sulfate	202	6.3	6.3
Buspirone Hydrochloride	8	6.2	6.2
Tizanidine Hydrochloride	13	6.2	6.2
Palivizumab	11	6.2	6.2
Amiodarone Hydrochloride	8	6.1	6.1
Felodipine Extended-Release Tablets	8	6.0	6.0
Felodipine	8	6.0	6.0
Febuxostat Tablets 40 Mg	7	5.9	5.9
Febuxostat Tablets 80 Mg	7	5.9	5.9
Rizatriptan Benzoate	7	5.9	5.9
Benzonatate	11	5.7	5.7
Acetaminophen, Chlorpheniramine Maleate, Phenylephrine Hcl	33	5.7	5.7
Fexofenadine Hcl	6	5.6	5.6
Etanercept	341	5.5	5.5
Fluticasone Furoate And Vilanterol Trifenatate	22	5.3	5.3
Hydroxyzine Hydrochloride	8	5.2	5.2
Hydroxyzine Hydrochloride Oral	8	5.2	5.2
Montelukast	50	5.2	5.2
Darunavir	9	5.1	5.1
Tobramycin	14	5.0	5.0
Mometasone Furoate And Formoterol Fumarate Dihydrate	9	5.0	5.0
Dolutegravir Sodium	5	4.8	4.8
Benralizumab	11	4.7	4.7
Obinutuzumab	9	4.7	4.7
Mepolizumab	26	4.5	4.5
Oseltamivir	4	4.3	4.3
Tobramycin Solution	6	4.3	4.3
Adalimumab	315	4.2	4.2
Micafungin Sodium	4	4.1	4.1
Lumacaftor And Ivacaftor	4	4.0	4.0
Calcium, Magnesium, Potassium, And Sodium Oxybates	4	4.0	4.0
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	19	4.0	4.0
Bendamustine Hcl	7	3.9	3.9
Nicotine	17	3.6	3.6
Tofacitinib	76	3.6	3.6
Fexofenadine Hydrochloride	9	3.6	3.6
Nicotine Polacrilex	15	3.4	3.4
Morphine Sulfate	46	3.3	3.3
Varenicline Tartrate	30	3.2	3.2
Loratadine And Pseudoephedrine Sulfate	3	3.2	3.2
Inclisiran	3	3.2	3.2
Sodium Oxybate	24	3.1	3.1
Ranibizumab	9	2.9	2.9
Bosutinib	3	2.9	2.9
Cariprazine	3	2.8	2.8
Ranolazine	3	2.5	2.5
Paricalcitol	4	2.4	2.4
Ledipasvir And Sofosbuvir	5	2.2	2.2
Hydrocodone Bitartrate	10	2.0	2.0
Dornase Alfa	4	1.8	1.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.